LOS ANGELES – Cedars-Sinai has received a $1.2 million grant to design a system using remote monitoring to predict heart attacks and other cardiovascular events.
Funding for the study comes from the California Initiative to Advance Precision Medicine.
“The governor’s precision medicine initiative creates an amazing opportunity to confront this leading health threat by leveraging team science and advanced data analytics in ways never before possible,” said Dr. Brennan Spiegel, director of Cedars-Sinai Health Services Research, in a statement, who will lead the study. “For us, that means trying to stay one step ahead of cardiovascular disease by predicting who may have a heart attack or stroke before it happens.”
The research team will look for the earliest signs of cardiovascular disease by monitoring patients remotely with a specialized watch that measures activity, sleep, heart rate and stress level. Participants will also report their levels of anxiety, depression and quality of life using a smartphone or computer.
Additionally, participants will send researchers finger-prick blood samples by mail, allowing doctors to assess a variety of biomarkers and measure more than 500 blood proteins.
Precision medicine aims to use data-driven tools and analysis to develop new diagnostics, therapies and insights into disease. The Cedars-Sinai study is one of six demonstration projects selected by the state precision medicine initiative, and will receive the funds over two years.
The teams in the California initiative will join forces to use data across research, clinical, environmental and population health settings to better diagnose, treat, manage and prevent disease.
“This study, across medical disciplines and in partnership with industry, addressing a critical clinical question, is an example of the outstanding projects that Precision Health at Cedars-Sinai is brilliantly positioned to address,” said Dr. Dermot McGovern, professor of Medicine and Biomedical Sciences and director of the Cedars-Sinai Precision Health. “Using big data and near-patient technologies together with outstanding clinical care to address a significant clinical problem is at the core of Cedars-Sinai Precision Health.”